MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
18.10
-0.05 (-0.28%)
Mar 9, 2026, 1:48 PM EDT - Market open
MLTX Market Cap
MLTX has a market cap or net worth of $1.30 billion as of March 9, 2026. Its market cap has decreased by -51.10% in one year.
Market Cap
1.30B
Enterprise Value
983.60M
1-Year Change
-51.10%
Ranking
Category
Stock Price
$18.10
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.30B, an increase of 35,982.44%. That is a compound annual growth rate of 326.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.30B | 38.39% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.41B |
| ORIC Pharmaceuticals | 1.38B |
| Zenas BioPharma | 1.36B |
| Corvus Pharmaceuticals | 1.32B |
| Immatics | 1.32B |
| EyePoint | 1.31B |
| Savara | 1.30B |
| Septerna | 1.29B |